Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status - Eisenhofer, G; Lenders, J W; Siegert, G; Bornstein, S R; Friberg, P; Milosevic, D; Manelli, M; Linehan, W M; Adams, K; Timmers, H J; Pacak, K (Eur J Cancer, 2011)